Literature DB >> 7910820

Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression.

F K Bahrani1, H L Mobley.   

Abstract

Proteus mirabilis, an agent of urinary tract infection, expresses at least four fimbrial types. Among these are the MR/P (mannose-resistant/Proteus-like) fimbriae. MrpA, the structural subunit, is optimally expressed at 37 degrees C in Luria broth cultured statically for 48 h by each of seven strains examined. Genes encoding this fimbria were isolated, and the complete nucleotide sequence was determined. The mrp gene cluster encoded by 7,293 bp predicts eight polypeptides: MrpI (22,133 Da), MrpA (17,909 Da), MrpB (19,632 Da), MrpC (96,823 Da), MrpD (27,886 Da), MrpE (19,470 Da), MrpF (17,363 Da), and MrpG (13,169 Da). mrpI is upstream of the gene encoding the major structural subunit gene mrpA and is transcribed in the direction opposite to that of the rest of the operon. All predicted polypeptides share > or = 25% amino acid identity with at least one other enteric fimbrial gene product encoded by the pap, fim, smf, fan, or mrk gene clusters.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910820      PMCID: PMC205519          DOI: 10.1128/jb.176.11.3412-3419.1994

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  37 in total

1.  Proteus urinary infections in childhood.

Authors:  P G Mann
Journal:  J Clin Pathol       Date:  1972-06       Impact factor: 3.411

2.  Nucleotide sequence of the papA gene encoding the Pap pilus subunit of human uropathogenic Escherichia coli.

Authors:  M Båga; S Normark; J Hardy; P O'Hanley; D Lark; O Olsson; G Schoolnik; S Falkow
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

3.  The adhesins and fimbriae of Proteus mirabilis strains associated with high and low affinity for the urinary tract.

Authors:  R A Adegbola; D C Old; B W Senior
Journal:  J Med Microbiol       Date:  1983-11       Impact factor: 2.472

4.  Haemagglutinins and fimbriae of Morganella, Proteus and Providencia.

Authors:  D C Old; R A Adegbola
Journal:  J Med Microbiol       Date:  1982-11       Impact factor: 2.472

5.  A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters.

Authors:  J W Warren; J H Tenney; J M Hoopes; H L Muncie; W C Anthony
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

6.  The fimA gene encoding the type-1 fimbrial subunit of Escherichia coli. Nucleotide sequence and primary structure of the protein.

Authors:  P Klemm
Journal:  Eur J Biochem       Date:  1984-09-03

7.  Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis.

Authors:  F J Silverblatt; I Ofek
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

8.  Investigation of the haemolytic activity of Proteus mirabilis strains.

Authors:  P G Peerbooms; A M Verweij; D M MacLaren
Journal:  Antonie Van Leeuwenhoek       Date:  1983-04       Impact factor: 2.271

9.  Structural basis of pilus subunit recognition by the PapD chaperone.

Authors:  M J Kuehn; D J Ogg; J Kihlberg; L N Slonim; K Flemmer; T Bergfors; S J Hultgren
Journal:  Science       Date:  1993-11-19       Impact factor: 47.728

10.  Symptomatic pyelonephritis in elderly men.

Authors:  R Gleckman; N Blagg; D Hibert; A Hall; M Crowley; A Pritchard; W Warren
Journal:  J Am Geriatr Soc       Date:  1982-11       Impact factor: 5.562

View more
  29 in total

Review 1.  Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria.

Authors:  Peter Chahales; David G Thanassi
Journal:  Microbiol Spectr       Date:  2015-10

Review 2.  Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek.

Authors:  Sean-Paul Nuccio; Andreas J Bäumler
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

3.  Molecular basis of two subfamilies of immunoglobulin-like chaperones.

Authors:  D L Hung; S D Knight; R M Woods; J S Pinkner; S J Hultgren
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

4.  Similarities and differences among 105 members of the Int family of site-specific recombinases.

Authors:  S E Nunes-Düby; H J Kwon; R S Tirumalai; T Ellenberger; A Landy
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

5.  Transcriptional analysis of the MrpJ network: modulation of diverse virulence-associated genes and direct regulation of mrp fimbrial and flhDC flagellar operons in Proteus mirabilis.

Authors:  Nadine J Bode; Irina Debnath; Lisa Kuan; Anjelique Schulfer; Maureen Ty; Melanie M Pearson
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

6.  Distinct Residues Contribute to Motility Repression and Autoregulation in the Proteus mirabilis Fimbria-Associated Transcriptional Regulator AtfJ.

Authors:  Nadine J Bode; Kun-Wei Chan; Xiang-Peng Kong; Melanie M Pearson
Journal:  J Bacteriol       Date:  2016-07-13       Impact factor: 3.490

7.  Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.

Authors:  Xin Li; C Virginia Lockatell; David E Johnson; M Chelsea Lane; John W Warren; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Characterization of Proteus mirabilis precocious swarming mutants: identification of rsbA, encoding a regulator of swarming behavior.

Authors:  R Belas; R Schneider; M Melch
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

9.  Characterization of 17 chaperone-usher fimbriae encoded by Proteus mirabilis reveals strong conservation.

Authors:  Lisa Kuan; Jessica N Schaffer; Christos D Zouzias; Melanie M Pearson
Journal:  J Med Microbiol       Date:  2014-05-08       Impact factor: 2.472

Review 10.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.